Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Moehler

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Onkologie|May 1, 2010
[HER2 testing and targeted therapy in advanced gastric cancer]Thomas Höhler, Josef Rüschoff, Karsten Ridwelski, et al.
Future Oncology (London, England)|March 27, 2007
Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4Ines Gockel, Carl C Schimanski, Markus Moehler, et al.
Frontiers in Oncology|June 14, 2019
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune SilencingKatrin Goepfert, Christiane Dinsart, Jean Rommelaere, et al.
Annals of Surgery|July 11, 2020
Response to the Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases"Hauke Lang, Michael Kloth, Markus Moehler, et al.
Annals of Translational Medicine|November 4, 2021
Cancer gene related characterization of patterns and point of recurrence after resection of colorectal liver metastasesHauke Lang, Janine Baumgart, Wilfried Roth, et al.
Oncotargets and Therapy|October 31, 2022
In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma CellsMaike Delic, Veronika Boeswald, Katrin Goepfert, et al.
Targeted Oncology|February 17, 2016
Immunotherapy for Gastric Cancer: A Focus on Immune CheckpointsMaria Alsina, Markus Moehler, Cinta Hierro, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonistsAlexander Stein, Markus Moehler, Jörg Trojan, et al.
Cells|October 27, 2022
Morbidity and Mortality of Neutropenic Patients in Visceral Surgery: A Narrative ReviewAnn-Kathrin Lederer, Fabian Bartsch, Markus Moehler, et al.
World Journal of Gastroenterology|July 9, 2008
Multidisciplinary management of gastric and gastroesophageal cancersMarkus Moehler, Orestis Lyros, Ines Gockel, et al.
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Onkologie|May 1, 2010
[HER2 testing and targeted therapy in advanced gastric cancer]Thomas Höhler, Josef Rüschoff, Karsten Ridwelski, et al.
Future Oncology (London, England)|March 27, 2007
Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4Ines Gockel, Carl C Schimanski, Markus Moehler, et al.
Frontiers in Oncology|June 14, 2019
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune SilencingKatrin Goepfert, Christiane Dinsart, Jean Rommelaere, et al.
Annals of Surgery|July 11, 2020
Response to the Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases"Hauke Lang, Michael Kloth, Markus Moehler, et al.
Annals of Translational Medicine|November 4, 2021
Cancer gene related characterization of patterns and point of recurrence after resection of colorectal liver metastasesHauke Lang, Janine Baumgart, Wilfried Roth, et al.
Oncotargets and Therapy|October 31, 2022
In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma CellsMaike Delic, Veronika Boeswald, Katrin Goepfert, et al.
Targeted Oncology|February 17, 2016
Immunotherapy for Gastric Cancer: A Focus on Immune CheckpointsMaria Alsina, Markus Moehler, Cinta Hierro, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonistsAlexander Stein, Markus Moehler, Jörg Trojan, et al.
Cells|October 27, 2022
Morbidity and Mortality of Neutropenic Patients in Visceral Surgery: A Narrative ReviewAnn-Kathrin Lederer, Fabian Bartsch, Markus Moehler, et al.
World Journal of Gastroenterology|July 9, 2008
Multidisciplinary management of gastric and gastroesophageal cancersMarkus Moehler, Orestis Lyros, Ines Gockel, et al.
Pageof 22